Re: "Does SEPR claim to have figured out WYE’s strategy for lifecycle management of Effexor before WYE itself did, even though SEPR never made any attempt to develop or monetize this “invention”? I find this hard to believe."
But if this argument goes to court then both patents would be invalid and you would have no winners. If WYE can demonstrate they already knew said "invention" then SEPR's patent dies, While WYE's patent is already a zombie.
Of course it would seam this argument is obvious to TEVA and others, so my guess is the only winners will be the lawyers,
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.